Please ensure Javascript is enabled for purposes of website accessibility

3 Top Stocks to Buy on The Dip

By Zhiyuan Sun - May 14, 2021 at 6:10AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

To get the most out of short-term lows, consider these stocks.

Buying top growth stocks during temporary sell-offs can be a very profitable venture. More often than not, selling activity around growth stocks comes from early investors taking profits after a short-term setback to their growth. Once the firms get their act together, they can attract new inflows of capital and reignite momentum. 

Some of the best stocks in this category right now are Peloton Interactive (PTON 13.60%)Maxar Technologies (MAXR 5.23%), and Teladoc Health (TDOC 6.13%). Shares are on sale, with declines of nearly 50% since their highs earlier this year. Let's look at how the digital fitness company, the space intelligence firm, and the telehealth provider can generate wealth for investors. 

Manager analyzing sales invoices.

Image source: Getty Images

1. Peloton Interactive

Peloton has found itself in hot water after reports emerged of manufacturing defects in its Tread+ treadmills. From Sept. 2018 to April 2021, the firm sold 125,000 units to customers. Its inherent safety issues lead to one death, as well as 29 moderate to serious injuries.  The company has announced a recall of all its Tread and Tread+ treadmills. Altogether, the equipments under recall are worth about $553 million. Peloton is offering customers full refunds and repairs. 

But I think that this issue will likely become a one-time setback for an otherwise iconic stay-at-home brand. For starters, the firm has over $2.69 billion in cash and investments on hand to offset potential recall liabilities. Second, in Q3 2021 (ended March 31), Peloton grew its revenue 141% year over year to $1.263 million. Simultaneously, its digital subscriber count grew by an astonishing 404% to 891,000. Over $5.4 million people are Peloton members. The digital fitness company is close to breaking even in terms of net income.

The heart of Peloton's business remains its signature tablet-integrated indoor bikes. Its setup allows customers to perform at-home cardio exercises while watching a live stream from a fitness coach, and compete with other Peloton users on a local leaderboard. The bikes are not affected by the recalls.

Aside from individual use, Peloton also has a substantial opportunity to mass deploy its bikes in establishments like hotels and fitness centers. Overall, I would highly consider grabbing some shares at 7.7 times revenue, given its solid growth rate before the recall occurred.

2. Maxar Technologies

Maxar is a leading provider of satellite imaging and space infrastructure. Since its inception, Maxar has launched more than 285 spacecraft with has 90 geostationary satellites currently in service. It has more than $25 billion in project backlogs over the next five years, mainly from government defense contracts. 

At the end of the day, satellite servicing is a high-maintenance, capital-intensive business. The company made exhausted efforts to recover its SiriusXM satellite in April due to a payload failure, which ended up costing Maxar a total cost of $28 million.  

Hence, its revenue only grew marginally (+3% year over year) to $392 million in Q1 2021. Nevertheless, the firm expects to generate $1.77 billion in sales and $255 million in operating cash flow for the full year. This is still a great space stock to buy now, trading at a mere 6.9 times earnings.

3. Teladoc Health 

One of the world's top telehealth platforms is facing headwinds after PepsiCo (PEP 1.31%) stopped using the service due to a lack of integration with its existing health plans. Keep in mind, PepsiCo's 120,000 U.S. employees account for only a fraction of the firm's 52 million paid U.S. members. Teladoc has sunk ample capital into becoming a one-stop medium for healthcare needs, providing consultations for primary care, behavioral health, chronic illnesses, and telepharmacy. It has thus far lagged behind in terms of providing enterprise healthcare

Until the massive shift to employer-based telehealth solutions completes, Teladoc remains the king of "commodity" telemedicine. During Q1 2021, its revenue grew by 151% year over year to $453.7 million. At the same time, its operating income less non-cash expenses (EBITDA) increased 429% to $56.6 million. In addition, its urgent-care-based model can quickly scale across the 175 countries it operates in (as opposed to an employer-based one). Since it is already an integrated stop for telemedicine, the company could develop an enterprise healthcare solution right away to match the shifting consumer dynamic. For all its growth, Teladoc stock is still well worth a shot it at 11 times forward revenue. 

Zhiyuan Sun has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Peloton Interactive and Teladoc Health. The Motley Fool recommends MAXAR TECHNOLOGIES LTD. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Peloton Interactive, Inc. Stock Quote
Peloton Interactive, Inc.
$13.53 (13.60%) $1.62
Pepsico, Inc. Stock Quote
Pepsico, Inc.
$177.33 (1.31%) $2.29
Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$40.32 (6.13%) $2.33
Maxar Technologies Stock Quote
Maxar Technologies
$28.39 (5.23%) $1.41

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/14/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.